Kelly Michele Malloy, MD, MBA, FACS
Manage Your Profile
About
Kelly Michele Malloy MD, MBA, FACS is a head and neck surgical oncologist at the University of Michigan where she is professor of otolaryngology- head and neck surgery and Chief Clinical Officer for the adult hospitals of Michigan Medicine Health. Dr. Malloy's clinical work focuses on the comprehensive surgical management of patients with head and neck malignancies, with additional expertise in head and neck melanoma and complex microvascular free tissue reconstruction. Her primary research interest is in surgical education, specifically in applications of simulation in otolaryngology; she is the immediate past chair of the Simulation Education Committee of the American Academy of Otolaryngology- Head and Neck Surgery. Dr. Malloy is the program director of the head and neck surgical oncology and microvascular reconstruction fellowship at Michigan; she is committed to the daily work of training the next generation of comprehensive head and neck surgeons and increasing the diversity of our field to better serve our patients. She also serves as the associate chief clinical officer for adult surgical and rehabilitation services at Michigan Medicine Health, overseeing 10 surgical and rehabilitation inpatient care units and a 32 room operating theater suite. A passionate advocate for gender and racial equity and inclusion, she has served as the inaugural co-chair for the American Head and Neck Society's Margaret F. Butler Outstanding Mentor of Women in Head and Neck Surgery Award. Most recently she was elected Finance Officer of the Women In Otolaryngology (WIO) Section and chairs the WIO Endowment Committee.
Qualifications
-
MBAUniversity of Michigan, Ann Arbor, Michigan, United States
2022 - 2025
Research Overview
Surgical simulation education, quality and performance improvement in otolaryngology and multidisciplinary inpatient surgical care.
Recent Publications
-
Forner D, Thomas EA, McLean SA, Stucken CL, Malloy KM, Heft Neal ME, Davis MJ. 2026 Oct 10;Proceeding / Abstract / PosterImpact of Nodal Yield and Dissection Extent on Regional Control in Head and Neck Melanoma
-
Adil AA, Smith JD, Almasri M, Lyden T, Blakely A, Ambrose M, Malloy KM, Stucken CL, Spector ME, Chinn SB, Prince MEP, Rosko AJ, Glazer TA, Casper KA, Heft-Neal ME. Oral Oncology, 2026 May 1; 176:Journal ArticleIn-office secondary tracheoesophageal puncture with immediate voicing in post-laryngectomy patients
DOI:10.1016/j.oraloncology.2026.107951 PMID: 41886965 -
Risch Z, Bellile E, Bughrara MS, Swiecicki PL, Casper K, Malloy K, Hogikyan N, Spector M, Shuman A, Stucken C, Chinn S, Chepeha DC, Jolly S, Mierzwa M, Bradford C, Eisbruch A, Carey T, Prince M, Wolf GT, Worden FP. Head and Neck, 2026 May 1; 48 (5): 1311 - 1318.Journal ArticleNeutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx
DOI:10.1002/hed.70132 PMID: 41403153 -
Mierzwa M, Brenner C. Journal of Molecular Diagnostics, 2026 Apr 30;Journal ArticleValidation of MyHPVscore: a high-performance HPV ctDNA lab developed test
-
Dalal PJ, Dermody SM, Ali H, Brummel C, Chad Brenner J, Buchakjian M, Casper KA, Chinn SB, Forner D, Hasan D, Malloy KM, McHugh J, Mierzwa M, Heft Neal ME, Prince ME, Shah J, Shuman AG, Stucken CL, Spector ME, Yalamanchi P, Worden FP, Swiecicki PL. Oto Open, 2026 Apr 1; 10 (2):Journal ArticleLate Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term Surveillance
DOI:10.1002/oto2.70259 -
Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. Clinical Cancer Research, 2026 Feb 15; 32 (4): 684 - 693.Journal ArticleFDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
DOI:10.1158/1078-0432.CCR-25-2820 PMID: 41385605 -
Tikhtman R, Hasan D, Gao R, Buchakjian M, Casper K, Chinn S, Forner D, Malloy K, Prince M, Stucken C, Yalamanchi P, Heft Neal M. 2025 Oct 13;Proceeding / Abstract / PosterPostoperative shoulder dysfunction following latissimus dorsi versus pectoralis major flap reconstruction
-
Regan SN, Shah J, Suresh K, Morales KA, Cao Y, Aryal M, Rosen BS, Walline H, Lee C, Aldous J, Swiecicki PL, Casper KA, Chinn SB, Malloy KM, Prince MEP, Stucken CL, Shuman AG, Heft-Neal M, Lyden TH, Blakely A, Ambrose M, Chad Brenner J, Worden FP, Mierzwa ML. Advances in Radiation Oncology, 2025 Oct 1; 10 (10):Journal ArticleProspective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx Cancer
DOI:10.1016/j.adro.2025.101832
Featured News & Stories